Literature DB >> 2357155

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.

J V Haxby1, C L Grady, E Koss, B Horwitz, L Heston, M Schapiro, R P Friedland, S I Rapoport.   

Abstract

Regional cerebral metabolic rates for glucose (rCMRglc), as measured with positron emission tomography, and neuropsychological function were studied longitudinally (range, 15 to 48 months) in 11 mildly impaired patients with dementia of the Alzheimer type (DAT) and compared with results from patients with moderate and severe DAT and from controls. At initial evaluation, association cortex metabolic asymmetries were greater in patients with DAT than in controls for all dementia severities and correlated significantly with neuropsychological discrepancies between visuospatial and language abilities in patients with moderate dementia. In mildly impaired patients, right-left metabolic asymmetries in the association cortices were directionally stable and became more pronounced over time. At initial evaluation, these patients had significant impairment, relative to controls, on tests of memory and attention to complex tasks but not on tests of language and visuospatial function. Memory, attention, language, and visuospatial impairments, however, all worsened significantly over time. In mildly impaired patients, correlations between right-left metabolic asymmetries and neuropsychological discrepancies were insignificant initially but were significant at last evaluation. These results demonstrate that heterogeneous nonmemory language and visuospatial impairments in early DAT are related to and predicted by the earlier-appearing distribution of metabolic reductions in the association neocortex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357155     DOI: 10.1001/archneur.1990.00530070043010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  51 in total

1.  Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.

Authors:  S I Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  FFT approximation in Alzheimer's disease.

Authors:  C Fornara; M Cursi; L Roveri; F Minicucci; T Locatelli; G Comi
Journal:  Ital J Neurol Sci       Date:  1998-08

Review 3.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

Review 4.  Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.

Authors:  David J Brooks
Journal:  NeuroRx       Date:  2005-04

5.  Asymmetry in auditory and spatial attention span in normal elderly genetically at risk for Alzheimer's disease.

Authors:  Mark W Jacobson; Dean C Delis; Mark W Bondi; David P Salmon
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

6.  Sustained attention in mild Alzheimer's disease.

Authors:  Anna Maria Berardi; Raja Parasuraman; James V Haxby
Journal:  Dev Neuropsychol       Date:  2005       Impact factor: 2.253

7.  Brain SPET perfusion in early Alzheimer's disease: where to look?

Authors:  Ingeborg Goethals; Christophe Van De Wiele; Daniel Slosman; Rudi Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08       Impact factor: 9.236

8.  Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis.

Authors:  Liping Fu; Linwen Liu; Jinming Zhang; Baixuan Xu; Yong Fan; Jiahe Tian
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

Review 9.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum.

Authors:  R Migliaccio; F Agosta; K Rascovsky; A Karydas; S Bonasera; G D Rabinovici; B L Miller; M L Gorno-Tempini
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.